| Date Filed | Type | Description |
| 06/16/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on EKSO BIONICS HOLDINGS, INC.|
Txns:
| Granted 72,993 shares
@ $0 |
|
| 06/09/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 05/08/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Exercised 97 options to buy
@ $0
Exercised 5,901 restricted stock units
@ $0
Granted 5,666 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 30 options to buy
@ $0 |
|
| 02/14/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $1.52, valued at
$44.1k
|
|
| 12/13/2022 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 33 options to buy
@ $0 |
|
| 09/13/2022 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 35 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 6 options to buy
@ $0 |
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Exercised 8 options to buy
@ $0
Exercised 1,083 restricted stock units
@ $0 |
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Exercised 3 options to buy
@ $0
Exercised 1,083 restricted stock units
@ $0 |
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 10 options to buy
@ $0 |
|
| 11/04/2020 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Exercised 445 restricted stock units
@ $0
Exercised 1 options to buy
@ $0 |
|
| 09/14/2020 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 6,509 options to buy
@ $10.12, valued at
$65.9k
|
|
| 09/09/2020 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 13 options to buy
@ $0 |
|
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 3,558 restricted stock units
@ $0 |
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 46,266 options to buy
@ $0.5, valued at
$23.1k
|
|
| 05/03/2019 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on FRESH DEL MONTE PRODUCE INC|
Txns:
| Granted 2,830 shares
@ $29.44, valued at
$83.3k
|
|
| 06/07/2018 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 38,216 options to buy
@ $2.27, valued at
$86.8k
|
|
| 09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |